Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1M 1.2M 4.61M 6.43M 6.46M 6.81M 4.66M 7.3M 12.12M 34.22M 53.22M 78.22M 100.56M 97.89M 104.63M 96.35M 93.03M
Cost of Revenue
1.12M 1.67M 4.69M 4.65M 4.56M 4.5M 1.73M 2.25M 2.7M 5.48M 7.45M 10M 11.58M 11.57M 13.4M 15.91M 21.75M
Gross Profit
-122.7K -463.72K -83.52K 1.77M 1.9M 2.31M 2.93M 5.05M 9.42M 28.74M 45.77M 68.23M 88.98M 86.31M 91.23M 80.44M 71.28M
Operating Income
-40.87M -42.79M -42.71M -41.41M -43.23M -42.71M -27.05M -24.65M -16.8M -309.41K 6.16M 26.33M 42.27M 46.06M 51.79M 50.19M 50.74M
Interest Income
729.09K 1.09M 1.41M 1.47M 1.32M 1.16M 1.05M 1.03M 895.02K 704.04K 380.31K 93.51K 42.37K 45.63K 58.04K 76.65K 104.3K
Pretax Income
-35.81M -37.58M -37.38M -35.81M -39.38M -38.11M -52.31M -47.69M -39.96M -18.85M 16.44M 33.49M 48.85M 45.64M 51.2M 50.44M 51.15M
Net Income
-35.86M -37.64M -41.28M -37.57M -38.89M -35.33M -42.56M -37.94M -31.71M -14.24M 15.17M 28M 40.47M 36.66M 41.97M 46.22M 49.07M
Selling & General & Admin
19.59M 20.64M 19.92M 19.63M 20.9M 21.14M 21.8M 22.26M 20.75M 21.61M 20.35M 22.01M 26.39M 24.95M 25.26M 21.09M 15.35M
Research & Development
20.17M 20.98M 22.35M 23.26M 23.63M 22.96M 21.52M 20.77M 18.68M 17.44M 14.88M 15.74M 16.52M 14.96M 13.89M 8.92M 5M
Other Expenses
1.09M 930.61K 216.91K -93.75K -219.94K n/a 655.2K 927.12K 927.12K 858.38K 662.36K 443.91K 515.62K 335.36K 289.94K 231.39K 184.89K
Operating Expenses
40.73M 42.33M 42.63M 43.19M 45.13M 45.02M 44.54M 44.26M 40.79M 40.33M 36.32M 38.61M 43.42M 40.25M 39.44M 30.24M 20.54M
Interest Expense
n/a n/a 3.39M 3.39M 3.39M 3.39M n/a 298.18K 298.18K 309.58K 318.64K 31.84K 42.37K 45.63K 58.04K 76.65K 104.3K
Selling & Marketing Expenses
3.58M 4.48M 5.18M 6.03M 6.72M 6.86M 6.67M 6.66M 6.4M 7.34M 8.11M 10.47M 14.85M 13.4M 14.51M 11.06M 5.59M
Cost & Expenses
40.85M 43M 47.32M 47.84M 49.69M 49.52M 46.27M 46.51M 43.49M 45.81M 43.77M 48.61M 55.01M 51.82M 52.84M 46.15M 42.29M
Income Tax Expense
46.61K 57.37K 3.9M 1.76M -495.12K -2.78M -9.75M -9.75M -8.25M -4.61M 1.28M 5.49M 8.38M 8.98M 9.24M 4.22M 2.33M
Shares Outstanding (Basic)
32.05M 33.05M 30.49M 30.12M 29.84M 31.26M 29.36M 29.09M 29.48M 30.87M 31.32M 32.47M 33.94M 28.94M 28.94M 28.79M 28.66M
Shares Outstanding (Diluted)
32.05M 33.05M 30.49M 30.12M 29.84M 31.26M 29.36M 29.09M 29.48M 30.87M 31.32M 32.47M 34.71M 29.95M 29.95M 29.74M 30M
EPS (Basic)
-1.17 -1.24 -1.35 -1.23 -1.29 -1.18 -1.42 -1.26 -1.04 -0.49 0.48 0.93 1.35 1.28 1.48 1.64 1.84
EPS (Diluted)
-1.17 -1.24 -1.35 -1.23 -1.29 -1.18 -1.42 -1.26 -1.04 -0.5 0.46 0.89 1.30 1.22 1.43 1.58 1.76
EBITDA
-36.02M -38.7M -38.67M -37.42M -41.77M -41.48M -40.4M -37.98M -30.01M -10.31M 10.54M 30.48M 46.07M 46.4M 52.08M 51.2M 54.07M
EBIT
-28.95M -39.21M -40M -38.7M -43.01M -42.71M -41.61M -39.21M -31.37M -8.31M 12.73M 32.84M 48.92M 45.7M 51.2M 49.67M 52.44M
Depreciation & Amortization
1.33M 1.38M 1.33M 1.28M 1.26M 1.26M 1.26M 1.28M 1.38M 1.31M 1.1M 882.01K 524.38K 335.36K 289.94K 231.39K 184.89K